An Alzheimer’s Treatment Debunked

The New York Times

More and more often, it seems, drugs that were widely thought to be effective against serious illnesses turn out to show little or no value when tested in large, impartial clinical trials insulated from drug company influence. The latest example is a class of drugs known as atypical antipsychotics that are commonly used to soothe agitation, delusions and aggression in people with Alzheimer’s disease.

A government-sponsored study published in The New England Journal of Medicine last week found that the drugs are no more effective than placebos for most patients and carry troubling side effects, like sedation and confusion.

This was the third major study in the last year to cast doubt on the atypical antipsychotics, which were supposedly a significant advance over the first generation of antipsychotics. The earlier drugs had been enormously successful in alleviating the symptoms of schizophrenia, allowing patients to leave hospitals. But they often caused severe side effects that the newer drugs were designed to avoid…


Leave a comment

Filed under Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s